Researchers are investigating a novel placenta-derived stem cell therapy for multiple sclerosis, a currently incurable degenerative neurological condition. A recent phase 1 clinical trial, with findings published in Scientific Reports, assessed the safety and...
As the world population ages, osteoarthritis (OA), a degenerative, “wear-and-tear” form of arthritis which most often occurs during middle age and onwards,[1] becomes more common and therefore more burdensome. Knee osteoarthritis, in particular, is a major cause of...
Positive early results have emerged from a clinical trial testing an umbilical cord tissue stem cell therapy for epidermolysis bullosa (EB), a currently incurable group of disorders which causes extremely fragile skin. The therapy has shown promise in relieving...
A review paper, newly published in the prestigious Pediatrics journal, statistically demonstrates that cord blood therapy for cerebral palsy is an effective treatment to improve the motor skills of children suffering from this condition. The paper is an analysis of...
A phase 1 trial of a novel cell therapy for lymphoma that is highly resistant to standard treatment (highly refractory lymphoma) has published very positive results in the Nature Medicine journal. The therapy, which uses natural killer (NK) cells derived from cord...
Getting older is not just about grey hair and wrinkles. The body can deteriorate, losing muscle tone and strength, making daily life activities more difficult and tiring. What’s more, the immune system also weakens, making older adults more likely to get sick and less...
Early Insights Into Placenta Stem Cell Therapy for Multiple Sclerosis
Evidence Supports Cord Blood Therapy for Cerebral Palsy
Cord Blood Cell Therapy Shows Promise in Lymphoma Treatment
